Cannabidiol (CBD) is one of the main pharmacologically active phytocannabinoids of
Cannabis sativa L. CBD is non-psychoactive but exerts a number of beneficial …

Cannabidiol (CBD) has become a fast-growing avenue for research in psychiatry, and
clinicians are challenged with understanding the implications of CBD for treating mental …

Background Cannabidiol (CBD) is one of the major constituents of Cannabis sativa L. that
lacks psychotomimetic and rewarding properties and inhibits the rewarding and reinforcing …

ABSTRACT Background and Aims Cocaine use disorder (CUD) is a significant public health
concern for which no efficacious pharmacological interventions are available. Cannabidiol …

Substance use/abuse is one of the main causes of depressive symptoms. Cannabis and
synthetic cannabinoids in particular gained significant popularity in the past years. There is …

Cannabinoids, including those found in cannabis, have shown promise as potential
therapeutics for numerous health issues, including pathological pain and diseases that …

Substance use disorder (SUD) is a serious public health problem worldwide for which
available treatments show limited effectiveness. Since the legalization of cannabis and the …

Cannabidiol (CBD), one of the main components of cannabis, is generally considered safe.
CBD crosses the placenta and its use during pregnancy is steadily increasing, the impact of …

We review the still scarce but growing literature on resilience to the effects of social stress on
the rewarding properties of drugs of abuse. We define the concept of resilience and how it is …

Previous preclinical studies have demonstrated that cannabidiol (CBD) and cannabigerol
(CBG), two non-psychotomimetic phytocannabinoids from Cannabis sativa, induce …